mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.01 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |